That doesn't signify they don't seem to be looking at it. Quite a few breakthrough therapy designations have already been granted for psilocybin in the treatment of resistant depression—that's, depression that does not reply to no less than two differing types of antidepressants—in addition to a broader acceptance could be about the horizon.But